Assyro AI

FDA Orange Book · active-ingredient family

Enalapril maleate; hydrochlorothiazide

Enalapril maleate; hydrochlorothiazide is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:VASERETIC · NDA 019221

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
VASERETICRLD×2BAUSCHNDA 019221ABJul 12, 1995

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2MPP PHARMAANDA 076486Oct 27, 2004
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2IVAX SUB TEVA PHARMSANDA 075736Mar 25, 2003
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2SENORES PHARMSANDA 075909ABOct 15, 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2CHARTWELL RXANDA 076116Sep 19, 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2COSETTEANDA 075727Sep 18, 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2RISINGANDA 075624Sep 18, 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE×2TARO PHARM INDSANDA 075788ABSep 18, 2001

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Enalapril maleate; hydrochlorothiazide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.